What drove the after-hours move in 2228.HK stock?

The after-hours drop to **HK$8.92** followed profit-taking and position adjustments ahead of XtalPi’s earnings due 25 Mar 2026. Traders cited revenue visibility and contract announcements for AI drug-discovery platforms as the key near-term catalysts.

What is Meyka AI's rating and recommendation for 2228.HK stock?

Meyka AI rates 2228.HK at **62.92** out of 100 with a **Grade B** and recommendation **HOLD**. The grade blends benchmark, sector, key metrics, growth, and forecasts; it is informational and not financial advice.

How does the Meyka forecast compare to current 2228.HK stock price?

Meyka AI's forecast model projects a 12‑month level of **HK$10.66**, versus the current price **HK$8.92**, implying an upside of **19.50%**. Forecasts are model-based projections and not guarantees; monitor earnings for confirmation.

HK Stocks

2228.HK XtalPi HKSE falls to HK$8.92 after hours 23 Mar 2026: AI earnings focus

ByHuzaifa Zahoor March 23, 2026March 23, 2026

The stock moved sharply after hours: 2228.HK stock closed at HK$8.92, down 6.79% on heavy volume after a day high of HK$9.30 and previous close HK$9.57. Investors are positioning ahead of an earnings release scheduled 25 Mar 2026 and watching XtalPi’s AI drug-discovery platforms for near-term revenue proof points. On the Hong Kong Stock Exchange (HKSE) this matters because valuation and AI partnerships will shape short-term trading in Hong Kong, with Meyka AI providing real-time model signals for hedged positions.